Zika Virus Infection

Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

ZIKA Vaccine in Naive Subjects

A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects.

Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG)

VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents

Adherence to Care for Children With Congenital Zika Virus Infection in Puerto Rico

Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area

Evaluation of Viral Replication by Tonate Virus (TONV) and Zika Virus (ZIKV), Within an ex Vivo Trophoblast and Placental Model

ZIKAlliance Natural History Study

Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia

Estimated Cumulative Incidence of Zika Infection at the End of the First Epidemic in the French West Indies in a Sample of Patients Followed for HIV Infection.

Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001)

Zika and Neurodevelopment Among Infants in Grenada

Safety and Immunogenicity of BBV121

Applying Wolbachia to Eliminate Dengue

Neurologic Manifestations of the Arbovirus Infection in Colombia

Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults

Efficacy of Aquatic Physiotherapy in Children With Microcephaly by Zika Virus Congenital Syndrome

Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA